Awareness of medication abortion among a nationally representative US sample, 2021-2022

被引:7
作者
Kaller, Shelly [1 ]
Upadhyay, Ushma D. [1 ]
Ralph, Lauren J. [1 ]
Schroeder, Rosalyn [1 ]
Biggs, M. Antonia [1 ]
机构
[1] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Bixby Ctr Global Reprod Hlth, Adv New Stand Reprod Hlth ANSIRH, San Francisco, CA 94143 USA
关键词
Abortion; Awareness; Knowledge; Medication abortion; Mifepristone; Panel research;
D O I
10.1016/j.contraception.2023.110078
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: Assess public awareness of medication abortion in the U.S. Study design: We conducted a cross-sectional survey in 2021-2022 with a probability-based sample, calculating the prevalence of medication abortion awareness and assessing its associations with participant characteristics using multivariable logistic regression. Results: A total of 45% of adults (7201/16,113) and 49% of eligible 15-17-year-old females (175/358) invited completed the survey. In all, 64% of 6992 participants assigned female at birth, and 57% of 360 participants assigned male reported awareness of medication abortion. Race, age, education, poverty level, religion, sexual identity, abortion history, and attitudes toward abortion legality were associated with differences in awareness. Conclusions: Medication abortion awareness differs by participant groups and is critical for expanding abortion access. Implications: Tailored health information for groups with less awareness of medication abortion may help spread knowledge of the method and how to access it. (c) 2023 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:4
相关论文
共 11 条
[1]   Examining Public Opinion about Abortion: A Mixed-Methods Systematic Review of Research over the Last 15 Years [J].
Adamczyk, Amy ;
Dillon, Leevia ;
Kim, Chunrye .
SOCIOLOGICAL INQUIRY, 2020, 90 (04) :920-954
[2]   Changes in the Frequency and Type of Barriers to Reproductive Health Care Between 2017 and 2021 [J].
Adler, Aliza ;
Biggs, M. Antonia ;
Kaller, Shelly ;
Schroeder, Rosalyn ;
Ralph, Lauren .
JAMA NETWORK OPEN, 2023, 6 (04) :e237461
[3]   Effectiveness, safety and acceptability of no-test medical abortion (termination of pregnancy) provided via telemedicine: a national cohort study [J].
Aiken, A. R. A. ;
Lohr, P. A. ;
Lord, J. ;
Ghosh, N. ;
Starling, J. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2021, 128 (09) :1464-1474
[4]   Requests for Self-managed Medication Abortion Provided Using Online Telemedicine in 30 US States Before and After the Dobbs v Jackson Women's Health Organization Decision [J].
Aiken, Abigail R. A. ;
Starling, Jennifer E. ;
Scott, James G. ;
Gomperts, Rebecca .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (17) :1768-1770
[5]   The future of medication abortion in a post-Roe world [J].
Aiken, Abigail R. A. ;
Upadhyay, Ushma D. .
BMJ-BRITISH MEDICAL JOURNAL, 2022, 377
[6]  
Guttmacher Institute, 2022, 100 days post-Roe: at least 66 clinics across 15 US states have stopped offering abortion care
[7]  
Guttmacher Institute, Performance of Abortions: Restrictions
[8]  
Quasem M., 2022, KFF health tracking poll: Views on and knowledge about abortion in wake of leaked Supreme Court opinion
[9]   "I was close to death!": abortion and medical risk on American television, 2005-2016 [J].
Sisson, Gretchen ;
Rowland, Brenly .
CONTRACEPTION, 2017, 96 (01) :25-29
[10]   Safety and Efficacy of Telehealth Medication Abortions in the US During the COVID-19 Pandemic [J].
Upadhyay, Ushma D. ;
Koenig, Leah R. ;
Meckstroth, Karen R. .
JAMA NETWORK OPEN, 2021, 4 (08) :E2122320